Search Results - "Samsonov, M Iu"

Refine Results
  1. 1

    Level of soluble tumor necrosis factor receptor type I in patients with systemic scleroderma by Alekperov, R T, Timchenko, A V, Samsonov, M Iu, Guseva, N G, Nasonov, E L

    Published in Terapevtic̆eskii arhiv (2004)
    “…To study content and clinical correlations of sTNF-RI in patients with systemic sclerosis (SS). Thirty nine SS patients were examined with enzyme immunoassay…”
    Get more information
    Journal Article
  2. 2

    Clinical value of soluble tumor necrosis factor-alpha receptors in patients with systemic lupus erythematosus by Krichevskaia, O A, Kliukvina, N G, Aleksandrova, E N, Samsonov, M Iu, Nasonov, E L

    Published in Klinicheskaia meditsina (2004)
    “…The study was undertaken to examine the clinical value of serum levels of soluble receptors of tumor necrosis factor-alpha with a molecular mass of 55 kDa…”
    Get more information
    Journal Article
  3. 3

    Soluble receptors of TNF-alpha with molecular mass 55 kDa in rheumatoid arthritis: clinical role by Stepanets, O V, Chichasova, N V, Nasonova, M B, Samsonov, M Iu, Nasonov, E L

    Published in Klinicheskaia meditsina (2003)
    “…To evaluate clinical implications of the serum level of soluable receptors of tumor necrosis factor alpha (TNFa) with molecular mass 55 kDa (rTNF-55R) in…”
    Get more information
    Journal Article
  4. 4

    Neopterin: new immunological marker of autoimmune rheumatic disease by Nasonov, E L, Samsonov, M Iu, Tilz, G, Fuchs, D

    Published in Klinicheskaia meditsina (2000)
    “…Serum neopterin (SN), concentration of soluble (s) TNF-receptors (R) with molecular mass 55 kD and sIL-2R, C-reactive protein (CRP), Willebrand factor antigen…”
    Get more information
    Journal Article
  5. 5

    Clinical value of soluble adhesion molecules in systemic scleroderma by Alekperov, R T, Timchenko, A V, Aleksandrova, E N, Samsonov, M Iu, Guseva, N G, Nasonova, E L

    Published in Klinicheskaia meditsina (2003)
    “…The aim of the trial was to study clinical significance of estimation of cell adhesion soluble molecules (CASM) in scleroderma systematica (SS). Quantitation…”
    Get more information
    Journal Article
  6. 6

    Soluble adhesion molecules in antiphospholipid syndrome associated with systemic lupus erythematosus and in primary antiphospholipid syndrome by Aleksandrova, E N, Novikov, A A, Reshetniak, T M, Kliukvina, N G, Reshetniak, D V, Samsonov, M Iu, Nasonov, E L

    Published in Terapevtic̆eskii arhiv (2002)
    “…To evaluate clinical implications of measurements of the level of soluble cell molecules of adhesion (sCMA) in systemic lupus erythematosus (SLE) with…”
    Get more information
    Journal Article
  7. 7

    Soluble vascular adhesion-1 molecule in Sneddon syndrome: clinical and prognostic value by Kalashnikova, L A, Aleksandrova, E N, Samsonov, M Iu, Dobrynina, L A, Novikov, A A, Amirov, M K, Nasonov, E L

    Published in Klinicheskaia meditsina (2002)
    “…Clinical significance of a soluble vascular adhesion-1 molecule (pVCAM-1) in Sneddon's syndrome (SS) was studied in 48 SS patients by examination of serum…”
    Get more information
    Journal Article
  8. 8

    Soluble receptors of TNF-alpha in rheumatoid arthritis by Nasonov, E L, Chichasova, N V, Samsonov, M Iu, Tilz, G P, Nikiforova, E L, Stepanets, O V, Nasonova, M B, Fuks, D

    Published in Klinicheskaia meditsina (2001)
    “…The serum level of soluble TNF-alpha receptors with molecular mass 55 kDa (sTNF-a55R) was measured by enzyme immunoassay with commercial kits in 30 patients…”
    Get more information
    Journal Article
  9. 9

    Soluble adhesion molecules (P-selectin, ICAM-1 and ICAM-3) in rheumatoid arthritis by Nasonov, E L, Samsonov, M Iu, Tilz, G P, Nikiforova, E L, Chichasova, N V, Imametdinova, G R, Ilich-Stoianovich, O, Baranov, A A, Fuchs, D, Nasonova, V A

    Published in Terapevtic̆eskii arhiv (1999)
    “…Investigation of serum levels and clinical role of soluble intercellular molecules of adhesion (pICAM-1, PICAM-3 and pP-selectin) in rheumatoid arthritis (RA)…”
    Get more information
    Journal Article
  10. 10

    Phospholipid antibodies in primary pulmonary hypertension by Chazova, I E, Samsonov, M Iu, Aleksandrova, E N, Nasonov, E L, Belenkov, Iu N

    Published in Terapevtic̆eskii arhiv (1994)
    “…Cardiolipin antibodies (CAb) were measured in 14 patients with primary pulmonary hypertension (PPH). These included 9 females and 5 males (mean age 36.8 +/-…”
    Get more information
    Journal Article
  11. 11

    Serum neopterin in Behçet's disease by Samsonov, M Iu, Prokaeva, T B, Madanat, V, Alekberova, Z S, Nasonov, E L, Fuks, D, Vakhter, Kh

    Published in Klinicheskaia meditsina (1995)
    “…Neopterin radioimmunoassay measurements (Henning, Berlin) were conducted in 26 male and 12 female patients (mean age 32 +/- 8.01) with Behcet's disease (BD)…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Neopterin: laboratory marker of cellular immunity activation in rheumatoid arthritis by Nasonov, E L, Samsonov, M Iu, Chichasova, N V, Imametdinova, G R, Nikiforova, E L, Aleksandrova, E N, Ilich-Stoyanovich, O, Fux, D, Vaxter, H

    Published in Terapevtic̆eskii arhiv (1998)
    “…Measurement of neopterin in the serum of patients with rheumatoid arthritis (RA). 59 patients with verified RA diagnosis (22 cases of joint lesion stage I-IIa,…”
    Get more information
    Journal Article
  14. 14

    Serum neopterin in hepatitis B by Samsonov, M Iu, Golban, T D, Nasonov, E L, Masenko, V P

    Published in Klinicheskaia meditsina (01-03-1992)
    “…Activation of the immunity system commonly followed the development of viral diseases. Neopterin is evidently a marker of the activation. Elevation of…”
    Get more information
    Journal Article
  15. 15

    The serum neopterin level in acute rheumatic fever by Samsonov, M Iu, Dzhuzenova, B S, Nasonov, E L, Meshcheriakov, V G, Belenkov, Iu N, Nasonova, V A

    Published in Terapevtic̆eskii arhiv (1992)
    “…Acute rheumatic fever (ARF) is a systemic inflammatory disease etiologically related to infection with group A streptococcus characterized by a broad spectrum…”
    Get more information
    Journal Article
  16. 16

    The clinical importance of the dynamic determination of the serum neopterin level in patients with dilated cardiomyopathy by Samsonov, M Iu, Nasonov, E L, Masenko, V P, Naumov, V G, Mareev, V Iu, Belenkov, Iu N

    Published in Terapevtic̆eskii arhiv (1991)
    “…Serum neopterin was measured over time (from 3 to 24 months) by RIA in 15 patients with dilated cardiomyopathy. Comparison with the clinical data revealed that…”
    Get more information
    Journal Article
  17. 17

    Antibodies to pathogens of Lyme's disease in patients with myocarditis and dilated cardiomyopathy by Skripnikova, I A, Samsonov, M Iu, Nasonov, E L, Ananéva, L P, Kovaleva, V Iu, Kobylianskiĭ, A G, Malakhov, V I, Naumov, V G, Belenkov, Iu N

    Published in Klinicheskaia meditsina (1993)
    “…The paper presents the information on the involvement of the cardiovascular system in the patients with Lyme's disease as well as the results of serological…”
    Get more information
    Journal Article
  18. 18

    Serum neopterin, bacteremia and viral antibodies in dilated cardiomyopathy by Aleksandrova, L Z, Nasonov, E L, Chankov, S V, Samsonov, M Iu, Ovtrakht, N V, Titov, V N

    Published in Terapevtic̆eskii arhiv (1994)
    “…Quantitation of neopterin and morphological examination of bacteria circulating in the blood of 28 patients with dilated cardiomyopathy gave evidence for…”
    Get more information
    Journal Article
  19. 19

    Immunoregulatory disorders and activation of the immune system in dilated cardiomyopathy by Nasonov, E L, Aleksandrova, L Z, Samsonov, M Iu, Aleksandrova, E N, Gracheva, L A

    Published in Terapevtic̆eskii arhiv (1988)
    “…The level of immunoregulatory lymphocytic subpopulations (CD3-, CD4-, CD8-cells, CD4/SD8 ratio, IaDr-positive cells, SD16-cells), lymphocyte natural…”
    Get more information
    Journal Article
  20. 20